|
ZNF682 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.754810E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.775370E-03 |
| Normal-vs-Stage2 |
3.071800E-01 |
| Normal-vs-Stage3 |
7.828600E-01 |
| Normal-vs-Stage4 |
4.423600E-01 |
| Stage1-vs-Stage2 |
6.986200E-01 |
| Stage1-vs-Stage3 |
5.326100E-02 |
| Stage1-vs-Stage4 |
7.808800E-01 |
| Stage2-vs-Stage3 |
4.302200E-01 |
| Stage2-vs-Stage4 |
6.915400E-01 |
| Stage3-vs-Stage4 |
4.812600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.569500E-04 |
| Normal-vs-AfricanAmerican |
2.589600E-02 |
| Normal-vs-Asian |
6.727200E-01 |
| Caucasian-vs-AfricanAmerican |
9.820800E-01 |
| Caucasian-vs-Asian |
9.112800E-01 |
| AfricanAmerican-vs-Asian |
9.237600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.3964000000063E-05 |
| Normal-vs-Female |
1.967570E-01 |
| Male-vs-Female |
6.961900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.546100E-02 |
| Normal-vs-Extreme_Weight |
2.056200E-02 |
| Normal-vs-Obese |
5.758600E-03 |
| Normal-vs-Extreme_Obese |
4.024000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.363800E-01 |
| Normal_Weight-vs-Obese |
4.387200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.194400E-01 |
| Extreme_Weight-vs-Obese |
4.830200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.599000E-01 |
| Obese-vs-Extreme_Obese |
5.221000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.735000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.168600E-04 |
| Normal-vs-Age(61-80Yrs) |
5.301400E-03 |
| Normal-vs-Age(81-100Yrs) |
6.672200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.040400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.105000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.364600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.563600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.658000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.900200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.51499999989646E-07 |
| Normal-VS-Type2 PRCC |
7.756200E-01 |
| Normal-VS-KIRP CIMP |
6.318600E-01 |
| Normal-VS-Unclassified PRCC |
3.805600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.23730000000245E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.489800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.021000E-03 |
| Type2 PRCC-VS-KIRP CIMP |
8.595000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.612400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.709200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.563900E-02 |
| Normal-vs-N1 |
3.236600E-01 |
| Normal-vs-N2 |
2.770300E-02 |
| N0-vs-N1 |
9.742400E-01 |
| N0-vs-N2 |
1.348620E-01 |
| N1-vs-N2 |
3.379800E-01 |
|
|
